All the top Biotech & Pharma news in one daily newsletter.
What to understand how these updates are formatted? Check-out the FAQ.
Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣
Looking to reach an audience of 700+ biotech and pharma professionals? Let’s chat. 👍
⬇️ The Good News ⬇️
THE GOOD
Approvals & Labels
Theramex’s menopause-induced osteoporosis peptide lands UK’s NICE recommendation (Eladynos)
Synthetic peptide, osteoporosis, menopause - Read more
THE GOOD
Business Development
Pathos AI buys worldwide license to Prelude Therapeutics PRMT5 inhibitor (PRT811)
Small molecule, solid tumor, glioma, melanoma, cancer - Read more
ArriVent BioPharma opts to license cancer asset as part of 2.5 years old $100M partnership with Aarvik Therapeutics
Antibody-drug conjugate, oncology, cancer - Read more
THE GOOD
Clinical Trials
DermBiont showcases initial positive Ph2a carcinoma trial data (SM-020)
Small molecule, topical, gorlin syndrome, carcinoma, cancer - Read more
Turnstone Biologics posts promising Ph1 TIL data, though financial concern sink stock
Tumor-infiltrating lymphocyte (TIL), cell therapy, colorectal cancer, head and neck cancer, uveal melanoma - Read more
THE GOOD
Earnings & Finances
A public health emergency is great news for Bavarian Nordic shareholders as stock jumps nearly 50% over the last week
Vaccine, infectious disease outbreak, monkeypox (mpox) - Read more
THE GOOD
Fundraises
Kalm Therapeutics $700k seed raise
Non-steroidal topical, medical device, atopic dermatitis, psoriasis - Read more
HistoSonics turns it up louder with $102M Series D for ultrasound-powered liver cancer treatment
Medical device, ultrasound, liver cancer - Read more
ViroCell Biologics complete oversubscribed financing round, terms undisclosed
CDMO, cell and gene therapy - Read more
THE GOOD
Investments
Abata Therapeutics nabs strategic investment from Bristol Myers Squibb
Regulatory T cells (Treg), autoimmune, type 1 diabetes, primary progressive multiple sclerosis (PPMS) - Read more
Insulet debuts 400k sqft insulin delivery device manufacturing site in Malaysia
Medical device, insulin delivery, diabetes, manufacturing - Read more
PRESENTED BY THE UBC SCHOOL OF BIOMEDICAL ENGINEERING
Unlock the Future of Healthcare Innovation

Join us online on Wednesday, September 25th, at 5:30 PM Pacific for an information session about UBC's new Micro-certificate in Innovation Leadership: Medical & Bio-Innovations.
Discover how this transformative program equips you with essential legal, strategic, and practical skills to bridge the gap between scientific breakthroughs and market success.
What to Expect:
Learn about the unique opportunities this program offers to advance your career.
Understand how to make a meaningful impact on healthcare.
Participate in a live Q&A session.
Don’t miss this opportunity—register now to secure your spot!🔗
⬇️ The Good News (Cont’d) ⬇️
THE GOOD
Partnerships
Zealand Pharma’s looking for a commercial partner for their obesity asset (petrelintide)
GLP-1/GLP-2, obesity - Read more
Nanoform collabs with Takeda on plasma-derived therapy development
Plasma-derived therapy, drug delivery, rare disease - Read more
NorthStar Medical Radioisotopes, Convergent Therapeutics strategic collab (CONV01-α)
Monoclonal antibody-radioisotope conjugate, radiopharma, prostate cancer - Read more
Nuntius Therapeutics, Taiho Pharmaceutical mRNA-based therapy cell-specific delivery collab
mRNA, cells-specific drug delivery, cancer, neurodegenerative diseases - Read more
THE GOOD
Politics & Policy
Medicare unveils first round of drug price negotiations enabled by the IRA
Inflation reduction act, drug pricing - Read more
THE GOOD
Research
Scale Biosciences launches “100 Million Cell Challenge”
Single cell projects, RNA sequencing, high-throughput sequencing - Read more
Denali Therapeutics showcases new brain drug delivery tech; animal studies
Engineered antibody, drug delivery, blood-brain barrier - Read more
Blackrock Neurotech’s brain implant (+ AI) returns voice to ALS patient
Medical device, brain implant, brain-computer interface, amyotrophic lateral sclerosis (ALS) - Read more
THE GOOD
Strategic Plans
Bayer’s massive restructuring not slowing down dealmaking according to BD head - Read more
ENJOYING THESE NEWSLETTERS?
Support TLDR Biotech.
It’s a lot of work to put together a daily newsletter, and it’s currently just me writing these things (+ one part-time contractor - no fancy editing team).
If you’re getting value out of these daily compilations, please consider a paid subscription (only $5/month) to support my continued work on this project.
⬇️ The Bad News ⬇️
THE BAD
Clinical Trals
SIGA Technologies Tpoxx antiviral misses primary endpoint, though CEO mentions this was “not entirely unexpected“
Small molecule, smallpox, monkeypox (mpox) - Read more
THE BAD
Lawsuits
Pfizer’s $107.5M Tagrisso patent win against AstraZeneca thrown out by Delaware judge
Small molecule, lung cancer, drug patent - Read more
THE BAD
Layoffs
Lykos Therapeutics can’t catch a break, as they cut 75% of their staff (including it’s Founder)
Small molecule, psychedelic, MDMA, depression - Read more
THE BAD
Research
How good is AI in drug discovery? Not great, according to recent Leash Bio contest
AI, drug discovery - Read more [Read more]
THE BAD
Strategic Plans
Lyra Therapeutics pauses LYR-220 development in an effort to refocus
Small molecule, chronic rhinosinusitis, nasal mesh, drug delivery - Read more
⬇️ The Ugly News ⬇️
THE UGLY
Withdrawals & Recalls
Two separate injectable sodium chloride solution recalls from B. Braun (particulate concerns) and Baxter (endotoxin concerns)
Sodium chloride solution injectable, metabolic alkalosis, anticoagulant - Read more
You’re all caught up on the latest Pharma & Biotech News!

Gif: theoffice on Giphy
TLDR Biotech wants to hear from you! 📣
Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝
Last thing - if you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️
Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here.


